{"schema_version":"1","generated_at":"2026-10-29T16:22:36.160Z","data_as_of":"2026-10-23","url":"https://www.findmykol.com/kol/maria-suarez-almazor","json_url":"https://www.findmykol.com/kol/maria-suarez-almazor/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"maria-suarez-almazor","name":"Maria Suarez-Almazor","credential":"MD","title":"Barnts Family Distinguished Professor, Department of Health Services Research","specialty":"Rheumatology","specialty_raw":"Rheumatology","therapeutic_area":"Rheumatology/Immunology","therapeutic_areas":["Rheumatology/Immunology"],"institution":"The University of Texas MD Anderson Cancer Center","institution_url":"https://www.findmykol.com/institution/the-university-of-texas-md-anderson-cancer-center","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1952341810","orcid":"0000-0001-5381-5797","openalex":"A5065216794"},"summary":"Maria Suarez-Almazor is Barnts Family Distinguished Professor, Department of Health Services Research at The University of Texas MD Anderson Cancer Center. OpenAlex indexes 590 publications with 45,568 citations (h-index 102). By OpenAlex citation count, this profile ranks in the top 5% of Rheumatology profiles in the FindMyKOL directory.","overview":{"text":"Maria Suarez-Almazor, MD, is Barnts Family Distinguished Professor, Department of Health Services Research at The University of Texas MD Anderson Cancer Center, Houston, TX. The public record shows 590 publications with 45,568 citations (h-index 102), centered on Rheumatoid Arthritis Research and Therapies, Cancer Immunotherapy and Biomarkers, Autoimmune and Inflammatory Disorders Research. It also documents industry payments reported by 4 companies, 10 NIH-funded awards (2000–2026).","bullets":["Most recent indexed publication: 2026 · Arthritis care & research","Top research focus: Rheumatoid Arthritis Research and Therapies","Open Payments reporting from 4 companies"],"generated_at":"2026-10-28"},"focus":{"indications":[{"label":"Rheumatoid Arthritis","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":1,"strength":1}],"research_topics":["Rheumatoid Arthritis Research and Therapies","Cancer Immunotherapy and Biomarkers","Autoimmune and Inflammatory Disorders Research","Musculoskeletal pain and rehabilitation","Natural Compounds in Disease Treatment"],"drugs_studied":{"total":5,"shown":3,"withheld":2,"rows":[{"name":"Xeljanz","generic":"Tofacitinib","trials":0,"payments":3,"publications":0,"mentions":3},{"name":"Belbuca","trials":0,"payments":1,"publications":0,"mentions":1},{"name":"Cosentyx","generic":"Secukinumab","trials":0,"payments":1,"publications":0,"mentions":1}]},"works_with":{"total":4,"shown":3,"withheld":1,"rows":[{"name":"Novartis Pharmaceuticals Corporation","trials":0,"payments":3,"mentions":3},{"name":"Pfizer Inc.","trials":0,"payments":3,"mentions":3},{"name":"Collegium Pharmaceutical, Inc.","trials":0,"payments":2,"mentions":2}]}},"scholarship":{"works_count":590,"cited_by_count":45568,"h_index":102,"i10_index":355,"pubmed_count":46,"latest_activity_year":2026,"citation_standing":{"top_percent":5,"cohort":"Rheumatology","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":0,"shown":0,"withheld":0,"rows":[],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2021,"last":2025},"rows_total":7,"shown":3,"withheld":4,"rows":[{"payer":"Collegium Pharmaceutical, Inc.","program_year":2025,"amount_usd":12518.73,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952341810"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":183,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952341810"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2024,"amount_usd":130.13,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952341810"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1952341810","source":"payments"},"funding":{"award_count":10,"fiscal_years":{"first":2000,"last":2026},"rows_total":52,"shown":3,"withheld":49,"rows":[{"project":"R25CA278726","title":"Methods Training for Comparative Effectiveness Research in Cancer","fiscal_year":2026,"amount_usd":315822,"organization":"UNIVERSITY OF TX MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R25CA278726"},{"project":"R25CA278726","title":"Methods Training for Comparative Effectiveness Research in Cancer","fiscal_year":2025,"amount_usd":316362,"organization":"UNIVERSITY OF TX MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R25CA278726"},{"project":"R25CA278726","title":"Methods Training for Comparative Effectiveness Research in Cancer","fiscal_year":2024,"amount_usd":316225,"organization":"UNIVERSITY OF TX MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R25CA278726"}],"source":"grants"},"congress":{"count":35,"years":{"first":2009,"last":2023},"societies":["AACR","ASCO"],"shown":3,"withheld":32,"rows":[{"title":"A systematic review with meta-analysis of radiotherapy adverse events in patients with cancer and lupus erythematosus.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2023,"role":"co_author","presentation_type":"unknown","contribution_type":"online_abstract","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e24092","source_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.e24092","status":"verified"},{"title":"Adverse events with the use of radiotherapy in patients with inflammatory arthritides and cancer: A systematic review and meta-analysis.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2023,"role":"co_author","presentation_type":"unknown","contribution_type":"online_abstract","doi":"https://doi.org/10.1200/jco.2023.41.16_suppl.e24090","source_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.e24090","status":"verified"},{"title":"Immune-related adverse events and symptom burden in patients with melanoma receiving adjuvant immune checkpoint inhibitor.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2022,"role":"co_author","presentation_type":"poster","contribution_type":"trials_in_progress","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps12147","source_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps12147","status":"verified"}],"source":"congress"},"publications":{"total":46,"shown":5,"withheld":41,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Survival Outcomes in Older Adults With Axial Spondyloarthritis and Concomitant Cancer.","year":2026,"journal":"Arthritis care & research","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42834520/","status":"verified"},{"title":"Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study.","year":2026,"journal":"Journal for immunotherapy of cancer","types":["Journal Article","Comparative Study","Observational Study","Multicenter Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42208976/","status":"verified"},{"title":"Dose reduction and discontinuation of non-tumor necrosis factor (TNF) biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs) for people with rheumatoid arthritis in remission or low disease activity.","year":2026,"journal":"The Cochrane database of systematic reviews","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42159078/","status":"verified"},{"title":"Safety of Immune Checkpoint Inhibitors in Cancer Patients With Preexisting Autoimmune Vasculitis.","year":2026,"journal":"ACR open rheumatology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41792579/","status":"verified"},{"title":"The advocacy effect: a grounded theory study on the inclusion of caregivers or nearest support persons in research to better understand patient outcomes in rheumatoid arthritis.","year":2025,"journal":"Rheumatology international","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40779031/","status":"verified"}],"most_cited":{"total":590,"shown":5,"withheld":585,"rows":[{"title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.","year":2004,"cited_by_count":4186,"type":"other","source_url":"https://openalex.org/A5065216794"},{"title":"Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline","year":2018,"cited_by_count":3707,"type":"article","source_url":"https://doi.org/10.1200/jco.2017.77.6385"},{"title":"Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group","year":2017,"cited_by_count":1988,"type":"article","source_url":"https://doi.org/10.1186/s40425-017-0300-z"},{"title":"2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","year":2012,"cited_by_count":1791,"type":"article","source_url":"https://doi.org/10.1002/acr.21641"},{"title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis","year":2008,"cited_by_count":1470,"type":"article","source_url":"https://doi.org/10.1002/art.23721"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Maria Angeles Lopez-Olivo","coauthored_works":109},{"name":"Noha Abdel‐Wahab","coauthored_works":51},{"name":"Peter Tugwell","coauthored_works":46}],"source":"works"},"presence":{"mentions":{"total":2,"shown":2,"rows":[{"url":"https://faculty.mdanderson.org/profiles/maria_suarez-almazor.html","platform":"other","status":"provisional"},{"url":"https://www.utsystem.edu/sites/regents-outstanding-teaching-awards/2020/suarez-almazor-maria","platform":"other","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":5,"shown":5,"rows":[{"value":"Board certified, American Board of Internal Medicine, Rheumatology (2011)","source_url":"https://faculty.mdanderson.org/profiles/maria_suarez-almazor.html","status":"verified","collected_at":"2026-10-28"},{"value":"Board certified, American Board of Internal Medicine (2010)","source_url":"https://faculty.mdanderson.org/profiles/maria_suarez-almazor.html","status":"verified","collected_at":"2026-10-28"},{"value":"PhD, Epidemiology, University of Alberta (1993)","source_url":"https://faculty.mdanderson.org/profiles/maria_suarez-almazor.html","status":"verified","collected_at":"2026-10-28"},{"value":"MS, Immunogenetics, University of Alberta (1989)","source_url":"https://faculty.mdanderson.org/profiles/maria_suarez-almazor.html","status":"verified","collected_at":"2026-10-28"},{"value":"MD, Universidad Nacional de Buenos Aires (1979)","source_url":"https://faculty.mdanderson.org/profiles/maria_suarez-almazor.html","status":"verified","collected_at":"2026-10-28"}]},"roles":{"total":6,"shown":3,"rows":[{"value":"American College of Rheumatology member (2003-2012)","source_url":"https://faculty.mdanderson.org/profiles/maria_suarez-almazor.html","status":"verified","collected_at":"2026-10-28"},{"value":"Editorial Board, Medical Decision Making","source_url":"https://faculty.mdanderson.org/profiles/maria_suarez-almazor.html","status":"verified","collected_at":"2026-10-28"},{"value":"Editorial Board, Clinical Rheumatology","source_url":"https://faculty.mdanderson.org/profiles/maria_suarez-almazor.html","status":"verified","collected_at":"2026-10-28"}]},"awards":{"total":4,"shown":3,"rows":[{"value":"America's Best Physicians (2022-2025)","source_url":"https://faculty.mdanderson.org/profiles/maria_suarez-almazor.html","status":"verified","collected_at":"2026-10-28"},{"value":"Honoree for Faculty Excellence in Education and Mentorship Advancement, Health Services Research (2024)","source_url":"https://faculty.mdanderson.org/profiles/maria_suarez-almazor.html","status":"verified","collected_at":"2026-10-28"},{"value":"Master of the American College of Rheumatology (2023)","source_url":"https://faculty.mdanderson.org/profiles/maria_suarez-almazor.html","status":"verified","collected_at":"2026-10-28"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"Adjunct Professor, Department of Medicine, Baylor College of Medicine, Houston, TX","source_url":"https://faculty.mdanderson.org/profiles/maria_suarez-almazor.html","status":"verified","collected_at":"2026-10-28"},{"value":"Professor, Section of Rheumatology and Clinical Immunology (joint appointment)","source_url":"https://faculty.mdanderson.org/profiles/maria_suarez-almazor.html","status":"verified","collected_at":"2026-10-28"}]}},"similar":[{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Jaffer Ajani","slug":"jaffer-ajani","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jaffer-ajani","json_url":"https://www.findmykol.com/kol/jaffer-ajani/profile.json"},{"name":"Funda Meric-Bernstam","slug":"funda-meric-bernstam","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Surgery","url":"https://www.findmykol.com/kol/funda-meric-bernstam","json_url":"https://www.findmykol.com/kol/funda-meric-bernstam/profile.json"},{"name":"David Felson","slug":"david-felson","institution":"Boston University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/david-felson","json_url":"https://www.findmykol.com/kol/david-felson/profile.json"},{"name":"Marc Hochberg","slug":"marc-hochberg","institution":"University of Maryland School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/marc-hochberg","json_url":"https://www.findmykol.com/kol/marc-hochberg/profile.json"},{"name":"Philip Mease","slug":"philip-mease","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/philip-mease","json_url":"https://www.findmykol.com/kol/philip-mease/profile.json"},{"name":"Michelle Petri","slug":"michelle-petri","institution":"Johns Hopkins University School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/michelle-petri","json_url":"https://www.findmykol.com/kol/michelle-petri/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":4,"funding":49,"congress":32,"publications":41,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-28"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-10-28"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-10-28"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-28"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-28"}},"methodology_url":"https://www.findmykol.com/about#methodology"}